Computational modelling of ocular pharmacokinetics
Pharmacokinetics in the eye is an important factor for the success of ocular drug delivery and treatment. Pharmacokinetic features determine the feasible routes of drug administration, dosing levels and intervals, and it has impact on eventual drug responses. Several physical, biochemical, and flow-related barriers limit drug exposure of anterior and posterior ocular target tissues during treatment during local (topical, subconjunctival, intravitreal) and systemic administration (intravenous, per oral). Mathematical models integrate joint impact of various barriers on ocular pharmacokinetics (PKs) thereby helping drug development. The models are useful in describing (top-down) and predicting (bottom-up) pharmacokinetics of ocular drugs. This is useful also in the design and development of new drug molecules and drug delivery systems. Furthermore, the models can be used for interspecies translation and probing of disease effects on pharmacokinetics. In this lecture, ocular pharmacokinetics and current modelling methods (noncompartmental analyses, compartmental, physiologically based, and finite element models) are introduced. Future challenges are also highlighted (e.g. intra-tissue distribution, prediction of drug responses, active transport).
“Mind reading” with brain scanners: Facts versus science fiction
Every thought is associated with a unique pattern of brain activity. Thus, in principle, it should be possible to use these activity patterns as "brain fingerprints" for different thoughts and to read out what a person is thinking based on their brain activity alone. Indeed, using machine learning considerable progress has been made in such "brainreading" in recent years. It is now possible to decode which image a person is viewing, which film sequence they are watching, which emotional state they are in or which intentions they hold in mind. This talk will provide an overview of the current state of the art in brain reading. It will also highlight the main challenges and limitations of this research field. For example, mathematical models are needed to cope with the high dimensionality of potential mental states. Furthermore, the ethical concerns raised by (often premature) commercial applications of brain reading will also be discussed.
Multimodal brain imaging to predict progression of Alzheimer’s disease
Cross-sectional and longitudinal multimodal brain imaging studies using positron emission tomography (PET) and magnetic resonance imaging (MRI) have provided detailed insight into the pathophysiological progression of Alzheimer’s disease. It starts at an asymptomatic stage with widespread gradual accumulation of beta-amyloid and spread of pathological tau deposits. Subsequently changes of functional connectivity and glucose metabolism associated with mild cognitive impairment and brain atrophy may develop. However, the rate of progression to a symptomatic stage and ultimately dementia varies considerably between individuals. Mathematical models have been developed to describe disease progression, which may be used to identify markers that determine the current stage and likely rate of progression. Both are very important to improve the efficacy of clinical trials. In this lecture, I will provide an overview on current research and future perspectives in this area.
Towards multipurpose biophysics-based mathematical models of cortical circuits
Starting with the work of Hodgkin and Huxley in the 1950s, we now have a fairly good understanding of how the spiking activity of neurons can be modelled mathematically. For cortical circuits the understanding is much more limited. Most network studies have considered stylized models with a single or a handful of neuronal populations consisting of identical neurons with statistically identical connection properties. However, real cortical networks have heterogeneous neural populations and much more structured synaptic connections. Unlike typical simplified cortical network models, real networks are also “multipurpose” in that they perform multiple functions. Historically the lack of computational resources has hampered the mathematical exploration of cortical networks. With the advent of modern supercomputers, however, simulations of networks comprising hundreds of thousands biologically detailed neurons are becoming feasible (Einevoll et al, Neuron, 2019). Further, a large-scale biologically network model of the mouse primary visual cortex comprising 230.000 neurons has recently been developed at the Allen Institute for Brain Science (Billeh et al, Neuron, 2020). Using this model as a starting point, I will discuss how we can move towards multipurpose models that incorporate the true biological complexity of cortical circuits and faithfully reproduce multiple experimental observables such as spiking activity, local field potentials or two-photon calcium imaging signals. Further, I will discuss how such validated comprehensive network models can be used to gain insights into the functioning of cortical circuits.